ArticleCureus2024
ChatGPT-3.5 Versus Google Bard: Which Large Language Model Responds Best to Commonly Asked Pregnancy Questions?
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The impact of ChatGPT on preoperative anxiety and postoperative depression in cesarean section: a prospective randomized trial.BMC pregnancy and childbirth · 2026Trial
- Addressing Commonly Asked Questions in Urogynecology: Accuracy and Limitations of ChatGPT.International urogynecology journal · 2025Article
- Can ChatGPT Provide Patient-Friendly and Reliable Information on Cervical Cancer Screening? A Study of ChatGPT-Generated Information in Polish.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
- Article
- Effectiveness of ChatGPT to provide esophageal cancer information: A SERVQUAL-based analysis.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large language models (LLM) have been widely used to provide information in many fields, including obstetrics and gynecology. Which model performs best in providing answers to commonly asked pregnancy questions is unknown. A qualitative analysis of Chat Generative Pre-Training Transformer Version 3.5 (ChatGPT-3.5) (OpenAI, Inc., San Francisco, California, United States) and Bard, recently renamed Google Gemini (Google LLC, Mountain View, California, United States), was performed in August of 2023. Each LLM was queried on 12 commonly asked pregnancy questions and asked for their references. Review and grading of the responses and references for both LLMs were performed by the co-authors individually and then as a group to formulate a consensus. Query responses were graded as "acceptable" or "not acceptable" based on correctness and completeness in comparison to American College of Obstetricians and Gynecologists (ACOG) publications, PubMed-indexed evidence, and clinical experience. References were classified as "verified," "broken," "irrelevant," "non-existent," and "no references." Grades of "acceptable" were given to 58% of ChatGPT-3.5 responses (seven out of 12) and 83% of Bard responses (10 out of 12). In regard to references, ChatGPT-3.5 had reference issues in 100% of its references, and Bard had discrepancies in 8% of its references (one out of 12). When comparing ChatGPT-3.5 responses between May 2023 and August 2023, a change in "acceptable" responses was noted: 50% versus 58%, respectively. Bard answered more questions correctly than ChatGPT-3.5 when queried on a small sample of commonly asked pregnancy questions. ChatGPT-3.5 performed poorly in terms of reference verification. The overall performance of ChatGPT-3.5 remained stable over time, with approximately one-half of responses being "acceptable" in both May and August of 2023. Both LLMs need further evaluation and vetting before being accepted as accurate and reliable sources of information for pregnant women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.